Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Regular Drug Eluting Stent Versus Dedicated Bifurcation Sirolimus-eluting Stent BiOSS LIM in Coronary Bifurcation Treatment - Randomized POLBOS II Study.

NCT02198300 is registered in ClinicalTrials.gov with Central Clinical Hospital of the Ministry of Internal Affairs and Administration, Warsaw, Poland as lead sponsor.

NCT NCT02198300
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02198300 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Regular Drug Eluting Stent Versus Dedicated Bifurcation Sirolimus-eluting Stent BiOSS LIM in Coronary Bifurcation Treatment - Randomized POLBOS II Study.
Lead sponsor
Central Clinical Hospital of the Ministry of Internal Affairs and Administration, Warsaw, Poland
Phase
Phase 4
Overall status
Completed
Start date
November 30, 2012
Completion date
March 31, 2015
Enrollment
202 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery disease